MedTrace Logo

Micra Transcatheter Pacing Study

NCT02004873 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 744

Last updated 2018-01-17

Study results available
· View outcomes & findings →

Summary

The purpose of this clinical study is to evaluate the safety and efficacy of the Micra Transcatheter Pacing System and to assess long term performance.

Conditions

  • Class I or II Indication for Implantation of a Single Chamber Ventricular Pacemaker According to ACC/AHA/HRS 2001 Guidelines and Any National Guidelines

Interventions

DEVICE

Micra Pacemaker Implant

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Dwight Reynolds · University of Oklahoma

  • Philippe Ritter · Hôpital Haut-Lévêque

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2015-05-31
Completion
2017-05-31

Countries

  • United States
  • Australia
  • Austria
  • Canada
  • China
  • Czechia
  • Denmark
  • France
  • Greece
  • Hungary
  • India
  • Italy
  • Japan
  • Malaysia
  • Netherlands
  • Serbia
  • South Africa
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02004873 on ClinicalTrials.gov